PT2299998T - Acidos gordos e glicerídeos de cadeia média como agentes nefroprotetores - Google Patents

Acidos gordos e glicerídeos de cadeia média como agentes nefroprotetores

Info

Publication number
PT2299998T
PT2299998T PT88451224T PT08845122T PT2299998T PT 2299998 T PT2299998 T PT 2299998T PT 88451224 T PT88451224 T PT 88451224T PT 08845122 T PT08845122 T PT 08845122T PT 2299998 T PT2299998 T PT 2299998T
Authority
PT
Portugal
Prior art keywords
nephroprotection
glycerides
agents
medium
fatty acids
Prior art date
Application number
PT88451224T
Other languages
English (en)
Portuguese (pt)
Inventor
Pichette Vincent
Francois Leblond
Lagraoui Mouna
Gagnon Lyne
Original Assignee
Prometic Pharma Smt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Pharma Smt Ltd filed Critical Prometic Pharma Smt Ltd
Publication of PT2299998T publication Critical patent/PT2299998T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT88451224T 2007-11-02 2008-11-03 Acidos gordos e glicerídeos de cadeia média como agentes nefroprotetores PT2299998T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98509407P 2007-11-02 2007-11-02

Publications (1)

Publication Number Publication Date
PT2299998T true PT2299998T (pt) 2018-04-02

Family

ID=40590499

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88451224T PT2299998T (pt) 2007-11-02 2008-11-03 Acidos gordos e glicerídeos de cadeia média como agentes nefroprotetores

Country Status (19)

Country Link
US (1) US9532962B2 (enExample)
EP (1) EP2299998B1 (enExample)
JP (1) JP5575655B2 (enExample)
KR (1) KR101601987B1 (enExample)
CN (1) CN101878028A (enExample)
AU (1) AU2008318196B2 (enExample)
BR (1) BRPI0818310A8 (enExample)
CA (1) CA2704286C (enExample)
DK (1) DK2299998T3 (enExample)
ES (1) ES2664594T3 (enExample)
IL (1) IL205362A (enExample)
MX (1) MX338513B (enExample)
MY (1) MY151439A (enExample)
NO (1) NO2299998T3 (enExample)
NZ (1) NZ584981A (enExample)
PT (1) PT2299998T (enExample)
RU (1) RU2519215C2 (enExample)
WO (1) WO2009055933A1 (enExample)
ZA (1) ZA201003030B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010127440A1 (en) 2009-05-04 2010-11-11 Prometic Biosciences Inc. Substituted aromatic compounds and pharmaceutical uses thereof
JP5706142B2 (ja) * 2010-04-28 2015-04-22 株式会社ファンケル フユボダイジュ花のエタノール抽出物を有効成分とする血中グルコース低下剤、内臓脂肪蓄積抑制剤、ｔｇ低下剤、糞中脂肪排泄促進剤
DK3443957T3 (da) 2010-10-27 2020-12-21 Liminal Biosciences Ltd Forbindelser og sammensætninger til behandling af cancer
JP5810166B2 (ja) 2011-08-26 2015-11-11 国立大学法人大阪大学 糖尿病性心血管合併症の予防・治療剤
KR20130023583A (ko) * 2011-08-29 2013-03-08 아주대학교산학협력단 파골세포 형성 억제 효과가 있는 카프르산 및 이를 포함하는 약학적 조성물
EP3065731B1 (en) 2013-11-05 2018-10-24 Hill's Pet Nutrition, Inc. Methods and compositions for improving kidney function
WO2017074266A1 (en) * 2015-10-30 2017-05-04 National University Of Singapore Androgen biosynthesis inhibitor
CN105559071A (zh) * 2016-01-12 2016-05-11 刘保惠 一种适用于肾病的特殊医学用途配方食品及其制备方法
JP2017214342A (ja) * 2016-06-02 2017-12-07 日清オイリオグループ株式会社 排尿障害の予防用又は改善用組成物
TWI749016B (zh) 2016-06-08 2021-12-11 董宇紅 具有奇數碳的脂類化合物及其作為醫藥組合物或者營養補充劑的用途
TW201825110A (zh) * 2016-12-21 2018-07-16 英商波麥堤克藥學Ｓｍｔ有限公司 用於預防或最小化上皮─間葉轉變之方法及組成物
JP7055429B2 (ja) * 2017-10-27 2022-04-18 学校法人北里研究所 慢性腎臓病の予防又は治療剤
WO2019155336A1 (en) * 2018-02-08 2019-08-15 Societe Des Produits Nestle S.A. Mct-based nutrition blend for providing health benefits in companion animals
CA3112073A1 (en) 2018-10-11 2020-04-16 Basf As Aromatic compounds and pharmaceutical uses thereof
CN109602012A (zh) * 2018-12-11 2019-04-12 李卫平 一种功能性低蛋白能量米及其制备方法
CN111184728B (zh) * 2020-02-20 2023-04-04 上海市儿童医院 海藻糖在肾病综合征中的应用
US20230404957A1 (en) * 2022-06-15 2023-12-21 Hill's Pet Nutrition, Inc. Pet Food Compositions
CN118592613B (zh) * 2024-08-05 2025-01-07 杭州康源食品科技有限公司 中链脂肪酸混合结构脂在改善膳食诱导的糖脂代谢紊乱中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602040A (en) 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
US4737384A (en) * 1985-11-01 1988-04-12 Allied Corporation Deposition of thin films using supercritical fluids
EP0583480A4 (en) 1992-02-07 1994-03-18 Tsumura & Co SIDE EFFECTS MITIGATION AGENT.
US6689700B1 (en) * 1999-11-02 2004-02-10 University Of Massachusetts Chemical fluid deposition method for the formation of metal and metal alloy films on patterned and unpatterned substrates
CN100348183C (zh) 2000-06-20 2007-11-14 营养科学公司 可用作抗微生物剂的中链脂肪酸
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
CA2444463C (en) * 2001-04-18 2012-03-20 Prometic Biosciences Inc. Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
CN1827766B (zh) 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
RU2213570C2 (ru) * 2001-08-22 2003-10-10 Санкт-Петербургская Государственная Химико-Фармацевтическая Академия ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКОЕ СРЕДСТВО ИЗ ЛИСТЬЕВ ЛИПЫ Folia Tilia И СПОСОБ ПОЛУЧЕНИЯ ЭКСТРАКТИВНЫХ ВЕЩЕСТВ
US7030168B2 (en) * 2001-12-31 2006-04-18 Advanced Technology Materials, Inc. Supercritical fluid-assisted deposition of materials on semiconductor substrates
US20040052836A1 (en) * 2002-09-13 2004-03-18 Li Luk Chiu Pharmaceutical compositions containing at least one stable liposphere having an improved shelf life
DE04708802T1 (de) 2003-02-07 2006-06-22 Prometic Biosciences Inc., Montreal Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese
DE602004006137T3 (de) 2003-07-25 2012-01-19 Prometic Biosciences Inc. Herstellung von metallsalzen von fettsäuren mit mittlerer kettenlänge
EP1940379A4 (en) 2005-09-30 2009-05-13 Jackson H M Found Military Med METHOD FOR THE TREATMENT OF HEMORRHAGIC SHOCKS AND ASSOCIATED DISEASES

Also Published As

Publication number Publication date
KR20100106958A (ko) 2010-10-04
CA2704286C (en) 2016-08-23
MX338513B (es) 2016-04-20
RU2519215C2 (ru) 2014-06-10
KR101601987B1 (ko) 2016-03-09
EP2299998A4 (en) 2011-03-30
EP2299998A1 (en) 2011-03-30
AU2008318196B2 (en) 2014-04-10
RU2010122302A (ru) 2011-12-10
AU2008318196A1 (en) 2009-05-07
IL205362A0 (en) 2010-12-30
NO2299998T3 (enExample) 2018-06-02
ES2664594T3 (es) 2018-04-20
BRPI0818310A2 (pt) 2017-10-10
EP2299998B1 (en) 2018-01-03
CN101878028A (zh) 2010-11-03
IL205362A (en) 2015-01-29
ZA201003030B (en) 2011-02-23
DK2299998T3 (en) 2018-03-26
CA2704286A1 (en) 2009-05-07
US20100286269A1 (en) 2010-11-11
MY151439A (en) 2014-05-30
BRPI0818310A8 (pt) 2017-12-26
NZ584981A (en) 2012-05-25
JP5575655B2 (ja) 2014-08-20
MX2010004856A (es) 2010-06-30
JP2011502174A (ja) 2011-01-20
US9532962B2 (en) 2017-01-03
WO2009055933A1 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
ZA201003030B (en) Medium-chain length fatty acids and glycerides as nephroprotection agents
EP2089014A4 (en) OMEGA-3 FATTY ACIDS AND DYSLIPIDEMIC AGENT FOR REDUCING APO-B LEVELS
EP2120920A4 (en) OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE
GB0915693D0 (en) Fatty acid formulations and methods of use thereof
LT2315740T (lt) Acetilinti riebalų rūgščių salicilatai ir jų panaudojimas
EP2459189A4 (en) FATTY ACIDS AS ANTI-INFLAMMATORY AGENTS
IL207309A (en) Lipases with high specificity towards short chain fatty acids and uses thereof
DK2132317T3 (da) Delta-8-desaturaser og anvendelse heraf i fremstillingen af polyumættede fedtsyrer
ZA201008170B (en) Polypeptides and methods for producing triacyglycerols comprising modified fatty acids
PT2408426T (pt) Composições oftálmicas baseadas em ácidos gordos poliinsaturados ómega 3 e ómega 6
IL218417A0 (en) Fatty acid niacin conjugates and their uses
BRPI0921467A8 (pt) enzimas e métodos para produzir ácidos graxos ômega-3
EP2083815A4 (en) STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCING APO-B MIRRORS
EP2234994A4 (en) MIXTURES OF FATTY ACIDS AND ALKYL ESTERS AND USES THEREOF
PL2214638T3 (pl) Kompozycja zawierająca wielonienasycone kwasy tłuszczowe i węgiel aktywny
EP2324119A4 (en) DELTA5 MUTANT DESATURASES AND THEIR USE IN PRODUCTION OF POLYUNSATURATED FATTY ACIDS
EP2173184A4 (en) OMEGA TYPE ENRICHED FATTY ACID COMPOSITION
EP2448431A4 (en) BARRIER COMPOSITIONS AND OVEN-COOKED FOOD ENRICHED WITH OMEGA-3 FATTY ACID
GB2464886B (en) Preparation of fatty acids in solid form
EP2114397A4 (en) NOVEL CONJUGATES OF POLY-UNSATURATED FATTY ACIDS WITH AMINES AND THERAPEUTIC USES THEREOF
ZA201201063B (en) Novel fatty acid desaturases and elongases and uses thereof
PL2390339T3 (pl) Delta-8 desaturazy i ich zastosowanie w wytwarzaniu polinienasyconych kwasów tłuszczowych
ZA201203767B (en) Branched-chain fatty acids and biological production thereof
EP1958612A4 (en) TREHALOSE FATTY ACID ESTER COMPOSITION
GB2444896B (en) Compositions comprising polyunsaturated fatty acids